Clinical Trial Update: Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing rivaroxaban to placebo for extended antithrombotic prophylaxis after laparoscopic colorectal cancer surgery; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Prevention of Venous Thromboembolism

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Fadoi Foundation, Italy | Conditions: Prevention of Venous Thromboembolism | Phase 3 | Status: COMPLETED